Daily news
Using evidence as the guiding star, the @ducrest Twitter timeline consists of the latest scientific publications in dermatology, cosmetic dermatology, cosmetics and Home-Use devices. Here you will find interesting information gleaned from science and technology sources as well as the lay press.
Beyond my #dermatology topic but very interesting – Remdesivir for COVID-19: challenges of underpowered studies…
https://twitter.com/i/web/status/1261289026092445700
Adjuvant nivolumab plus ipilimumab or nivolumab monotherapy vs placebo in patients with resected stage IV melanoma…
https://twitter.com/i/web/status/1261285333246902274
Increased usage of botulinum toxin and hyaluronic acid fillers in young adults onlinelibrary.wiley.com/doi/10.1111/jd……
https://twitter.com/i/web/status/1261279065912291329
RT @MishaRosenbach: Thanks @ducrest; this @BrJDermatol paper from Spain on #derm rashes associated w #COVID19 is really a must read for all…
RT @ducrest: @BCNHealthHub @almiralldg @FLYING_HEALTH @AsabysPartners @zensei_app @FrontiersHealth @ticbiomed @dhealthtoday @TWDigitalHealt…
@BCNHealthHub @almiralldg @FLYING_HEALTH @AsabysPartners @zensei_app @FrontiersHealth @ticbiomed @dhealthtoday…
https://twitter.com/i/web/status/1261226668796055553
Classification of the cutaneous manifestations of COVID‐19 (375 cases from Spain) via @BrJDermatol and comment…
https://twitter.com/i/web/status/1261203991020568576
@BCNHealthHub @almiralldg @FLYING_HEALTH @AsabysPartners @zensei_app @FrontiersHealth @ticbiomed @dhealthtoday…
https://twitter.com/i/web/status/1261203127224713220
@BCNHealthHub @almiralldg @FLYING_HEALTH @AsabysPartners @zensei_app @FrontiersHealth @ticbiomed @dhealthtoday…
https://twitter.com/i/web/status/1261179321030520833
RT @ducrest: @JIDJournal Success to #VirtualSID2020 thanks to @SocInvestDerm @JIDJournal and @BrJDermatol
Research in #dermatology #derma…